Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of fecal microbiota transplantation with capsules on the prevention of metabolic syndrome among patients with obesity
Jessica R. Allegretti, Zain Kassam, Jonathan Hurtado, et al.
HORMONES (2021) Vol. 20, Iss. 1, pp. 209-211
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review
Mohammad M. Karimi, Niyousha Shirsalimi, Zahra Hashempour, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 17
Encyclopedia of fecal microbiota transplantation: a review of effectiveness in the treatment of 85 diseases
Yun Wang, Sheng Zhang, Thomas J. Borody, et al.
Chinese Medical Journal (2022)
Open Access | Times Cited: 66
The 7-α-dehydroxylation pathway: An integral component of gut bacterial bile acid metabolism and potential therapeutic target
Journey L. Wise, Bethany P. Cummings
Frontiers in Microbiology (2023) Vol. 13
Open Access | Times Cited: 29
Unraveling the Microbiome–Human Body Axis: A Comprehensive Examination of Therapeutic Strategies, Interactions and Implications
Gabriel Olteanu, Maria-Alexandra Pană, Ștefan Busnatu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5561-5561
Open Access | Times Cited: 12
Dietary resistant starch supplementation increases gut luminal deoxycholic acid abundance in mice
Melanie A. Reuter, Madelynn Tucker, Zara Marfori, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Faecal Microbiota Transplantation and Chronic Kidney Disease
Ji Bian, Ann Liebert, Brian Bicknell, et al.
Nutrients (2022) Vol. 14, Iss. 12, pp. 2528-2528
Open Access | Times Cited: 34
Impact of Fecal Microbiota Transplantation on Gut Bacterial Bile Acid Metabolism in Humans
Jessica-Miranda Bustamante, Tyson Dawson, Caitlin Loeffler, et al.
Nutrients (2022) Vol. 14, Iss. 24, pp. 5200-5200
Open Access | Times Cited: 34
Dysregulated bile acid homeostasis: unveiling its role in metabolic diseases
Yanyan Wang, Huangru Xu, Xiqiao Zhou, et al.
Medical Review (2024) Vol. 4, Iss. 4, pp. 262-283
Open Access | Times Cited: 8
Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation
С. М. Ткач, Andrii Dorofeyev, Iurii Kuzenko, et al.
Medicina (2022) Vol. 58, Iss. 1, pp. 84-84
Open Access | Times Cited: 25
Probiotic Mechanisms Affecting Glucose Homeostasis: A Scoping Review
Maša Primec, Tomaž Langerholc
Life (2022) Vol. 12, Iss. 8, pp. 1187-1187
Open Access | Times Cited: 23
Advances in fecal microbiota transplantation for the treatment of diabetes mellitus
Juan Zhang, Honggang Wang, Ying Liu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 5
Shifts in gut microbiota and their metabolites induced by bariatric surgery. Impact of factors shaping gut microbiota on bariatric surgery outcomes
Carolina Gutiérrez‐Repiso, Isabel Moreno‐Indias, Francisco J. Tinahones
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 22, Iss. 4, pp. 1137-1156
Closed Access | Times Cited: 29
Microbiome characterization of patients with Crohn disease and the use of fecal microbiota transplantation: A review
Shiju Chen, Daya Zhang, Da Li, et al.
Medicine (2025) Vol. 104, Iss. 4, pp. e41262-e41262
Open Access
Trust the gut: Outcomes of gut microbiota transplant in metabolic and cognitive disorders
Maria Angela Guzzardi, Federica La Rosa, Patricia Iozzo
Neuroscience & Biobehavioral Reviews (2023) Vol. 149, pp. 105143-105143
Open Access | Times Cited: 9
The gut microbiota and its products: Establishing causal relationships with obesity related outcomes
Lili Li, Yubing Zhang, John R. Speakman, et al.
Obesity Reviews (2021) Vol. 22, Iss. 12
Closed Access | Times Cited: 19
Ten reasons gastroenterologists and hepatologists should be treating obesity
Michael Camilleri, Emad El‐Omar
Gut (2023) Vol. 72, Iss. 6, pp. 1033-1038
Closed Access | Times Cited: 7
Over-feeding the gut microbiome: A scoping review on health implications and therapeutic perspectives
Monica Barone, Federica D’Amico, Marco Fabbrini, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 41, pp. 7041-7064
Open Access | Times Cited: 14
Does the Gut Microbiome Play a Role in Obesity in Type 1 Diabetes? Unanswered Questions and Review of the Literature
Heba M. Ismail, Carmella Evans‐Molina
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 9
The Role of Gut Microbiota Modulation Strategies in Obesity: The Applications and Mechanisms
Lingyue Shan, Akanksha Tyagi, Umair Shabbir, et al.
Fermentation (2022) Vol. 8, Iss. 8, pp. 376-376
Open Access | Times Cited: 9
Clinical trials targeting the gut-microbiome to effect ocular health: a systematic review
Matthew W. Russell, Justin C. Muste, Blanche L. Kuo, et al.
Eye (2023) Vol. 37, Iss. 14, pp. 2877-2885
Closed Access | Times Cited: 5
An open-label pilot trial of faecal microbiome transfer to restore the gut microbiome in anorexia nervosa: protocol
Brooke C. Wilson, José G. B. Derraik, Benjamin B. Albert, et al.
BMJ Open (2023) Vol. 13, Iss. 7, pp. e070616-e070616
Open Access | Times Cited: 5
Gut Microbiota as an Emerging Therapeutic Avenue for the Treatment of Nonalcoholic Fatty Liver Disease
Tanya Ralli, Yub Raj Neupane, Zoya Saifi, et al.
Current Pharmaceutical Design (2021) Vol. 27, Iss. 46, pp. 4677-4685
Closed Access | Times Cited: 11
Beneficial metabolic effects of PAHSAs depend on the gut microbiota in diet-induced obese mice but not in chow-fed mice
Jennifer Lee, Kerry Wellenstein, Ali Rahnavard, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 28
Open Access | Times Cited: 1
Fecal Microbiota Transplantation in Diseases Not Associated with Clostridium difficile: Current Status and Future Therapeutic Option
С. М. Ткач, Andrii Dorofeyev, Iurii Kuzenko, et al.
Advances in predictive, preventive and personalised medicine (2023), pp. 275-308
Closed Access | Times Cited: 3
Host—microbial interactions in metabolic diseases: from diet to immunity
Ju-Hyung Lee, Joo‐Hong Park
The Journal of Microbiology (2022) Vol. 60, Iss. 6, pp. 561-575
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top